Back to
UBS Group AG
NNNN6 quarters
Position history for
UBS Group AG's holdings in ANBIO BIOTECHNOLOGY
Yes. Ubs holds 828 shares of NNNN (Anbio Biotechnology), worth $11,352, as of its Q2 2026 13F filing. It reduced the position by 5,511 shares (-86.9%) from Q1 2026. Ubs has held NNNN since Q1 2025, across 6 quarterly 13F filings.
Current Value
$11,352
Current Shares
828
Total Value Change
-$31,453
Total Shares Change
-4,910
Quarter-by-Quarter History
Other major holders of NNNN: GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP